131 related articles for article (PubMed ID: 7643626)
1. Expression of FLT3 receptor and FLT3-ligand in human leukemia-lymphoma cell lines.
Meierhoff G; Dehmel U; Gruss HJ; Rosnet O; Birnbaum D; Quentmeier H; Dirks W; Drexler HG
Leukemia; 1995 Aug; 9(8):1368-72. PubMed ID: 7643626
[TBL] [Abstract][Full Text] [Related]
2. Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells.
Drexler HG
Leukemia; 1996 Apr; 10(4):588-99. PubMed ID: 8618433
[TBL] [Abstract][Full Text] [Related]
3. Expression of the flt3 receptor and its ligand on hematopoietic cells.
Brasel K; Escobar S; Anderberg R; de Vries P; Gruss HJ; Lyman SD
Leukemia; 1995 Jul; 9(7):1212-8. PubMed ID: 7630197
[TBL] [Abstract][Full Text] [Related]
4. Expression of the FLT3 gene in human leukemia-lymphoma cell lines.
DaSilva N; Hu ZB; Ma W; Rosnet O; Birnbaum D; Drexler HG
Leukemia; 1994 May; 8(5):885-8. PubMed ID: 8182945
[TBL] [Abstract][Full Text] [Related]
5. Effects of FLT3 ligand on human leukemia cells. I. Proliferative response of myeloid leukemia cells.
Dehmel U; Zaborski M; Meierhoff G; Rosnet O; Birnbaum D; Ludwig WD; Quentmeier H; Drexler HG
Leukemia; 1996 Feb; 10(2):261-70. PubMed ID: 8637235
[TBL] [Abstract][Full Text] [Related]
6. Expression of type III receptor tyrosine kinases FLT3 and KIT and responses to their ligands by acute myeloid leukemia blasts.
Stacchini A; Fubini L; Severino A; Sanavio F; Aglietta M; Piacibello W
Leukemia; 1996 Oct; 10(10):1584-91. PubMed ID: 8847893
[TBL] [Abstract][Full Text] [Related]
7. Human FLT3/FLK2 receptor tyrosine kinase is expressed at the surface of normal and malignant hematopoietic cells.
Rosnet O; Bühring HJ; Marchetto S; Rappold I; Lavagna C; Sainty D; Arnoulet C; Chabannon C; Kanz L; Hannum C; Birnbaum D
Leukemia; 1996 Feb; 10(2):238-48. PubMed ID: 8637232
[TBL] [Abstract][Full Text] [Related]
8. Effects of FLT3 ligand on proliferation and survival of myeloid leukemia cells.
Drexler HG; Meyer C; Quentmeier H
Leuk Lymphoma; 1999 Mar; 33(1-2):83-91. PubMed ID: 10194124
[TBL] [Abstract][Full Text] [Related]
9. FLT3 mutations in acute myeloid leukemia cell lines.
Quentmeier H; Reinhardt J; Zaborski M; Drexler HG
Leukemia; 2003 Jan; 17(1):120-4. PubMed ID: 12529668
[TBL] [Abstract][Full Text] [Related]
10. Src family tyrosine kinases are activated by Flt3 and are involved in the proliferative effects of leukemia-associated Flt3 mutations.
Robinson LJ; Xue J; Corey SJ
Exp Hematol; 2005 Apr; 33(4):469-79. PubMed ID: 15781338
[TBL] [Abstract][Full Text] [Related]
11. Effects of Flt3 ligand and interleukin-7 on in vitro growth of acute lymphoblastic leukemia cells.
Eder M; Hemmati P; Kalina U; Ottman OG; Hoelzer D; Lyman SD; Ganser A
Exp Hematol; 1996 Feb; 24(2):371-7. PubMed ID: 8641368
[TBL] [Abstract][Full Text] [Related]
12. The flt3 ligand: a hematopoietic stem cell factor whose activities are distinct from steel factor.
Lyman SD; Brasel K; Rousseau AM; Williams DE
Stem Cells; 1994; 12 Suppl 1():99-107; discussion 108-10. PubMed ID: 7535149
[TBL] [Abstract][Full Text] [Related]
13. Expression of bcl-2 mRNA and protein in leukemia-lymphoma cell lines.
Steube KG; Jadau A; Teepe D; Drexler HG
Leukemia; 1995 Nov; 9(11):1841-6. PubMed ID: 7475272
[TBL] [Abstract][Full Text] [Related]
14. Effects of SU5416, a small molecule tyrosine kinase receptor inhibitor, on FLT3 expression and phosphorylation in patients with refractory acute myeloid leukemia.
O'Farrell AM; Yuen HA; Smolich B; Hannah AL; Louie SG; Hong W; Stopeck AT; Silverman LR; Lancet JE; Karp JE; Albitar M; Cherrington JM; Giles FJ
Leuk Res; 2004 Jul; 28(7):679-89. PubMed ID: 15158089
[TBL] [Abstract][Full Text] [Related]
15. Normal and oncogenic FLT3.
Naoe T; Kiyoi H
Cell Mol Life Sci; 2004 Dec; 61(23):2932-8. PubMed ID: 15583855
[TBL] [Abstract][Full Text] [Related]
16. Ligand for FLT3/FLK2 receptor tyrosine kinase regulates growth of haematopoietic stem cells and is encoded by variant RNAs.
Hannum C; Culpepper J; Campbell D; McClanahan T; Zurawski S; Bazan JF; Kastelein R; Hudak S; Wagner J; Mattson J
Nature; 1994 Apr; 368(6472):643-8. PubMed ID: 8145851
[TBL] [Abstract][Full Text] [Related]
17. Effects of flt3 ligand on acute myeloid and lymphocytic leukemic blast cells from children.
McKenna HJ; Smith FO; Brasel K; Hirschstein D; Bernstein ID; Williams DE; Lyman SD
Exp Hematol; 1996 Feb; 24(2):378-85. PubMed ID: 8641369
[TBL] [Abstract][Full Text] [Related]
18. [Mutations of growth factor receptor Flt3 in acute myeloid leukemia: transformation of myeloid cells by Ras-dependent and Ras-independent mechanisms].
Müller-Tidow C; Steur C; Mizuki M; Schwäble J; Brandts C; Berdel WE; Serve H
Dtsch Med Wochenschr; 2002 Oct; 127(42):2195-200. PubMed ID: 12397548
[TBL] [Abstract][Full Text] [Related]
19. Stem cell factor, but not flt3 ligand, induces differentiation and activation of human mast cells.
Hjertson M; Sundström C; Lyman SD; Nilsson K; Nilsson G
Exp Hematol; 1996 May; 24(6):748-54. PubMed ID: 8635531
[TBL] [Abstract][Full Text] [Related]
20. Effects of FLT3 ligand on human leukemia cells. II. Agonistic and antagonistic effects of other cytokines.
Dehmel U; Quentmeier H; Drexler HG
Leukemia; 1996 Feb; 10(2):271-8. PubMed ID: 8637236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]